EX-99.1 2 hims-20230630x8xkearningre.htm EX-99.1 Document


Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Revenue of $207.9 million, up 83% year-over-year in Q2 2023

Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million in Q2 2023

Subscribers grew to 1.3 million, up 74% year-over-year in Q2 2023

Raises full year 2023 revenue guidance to a range of $830 million to $850 million and Adjusted EBITDA guidance to a range of $35 million to $40 million


SAN FRANCISCO, August 7, 2023 – Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today reported financial results for the second quarter ended June 30, 2023.

“This quarter marks a significant turning point for Hims & Hers, where step-change progress was made in transforming our company from an access-oriented company, towards a platform offering a personalized patient experience,” said Andrew Dudum, co-founder and CEO. “The capabilities that we have spent years building allow us to offer unique and differentiated products across our current categories, as well as seamlessly enter new categories such as Cardiovascular Health and Weight Management. These are some of the most commonly occurring and emotionally resonant conditions, and by addressing them, we are one giant step closer towards having the ability to improve the life of every individual in the world.”

“We are excited by the progress made this quarter, which we believe sets that foundation for long-term growth at an attractive margin profile through distinct competitive advantages,” said Yemi Okupe, CFO. “Our economic flywheel is clearly working. It has enabled us to strategically bring highly sought after personalized products to very attractive price points, and simultaneously expand margins. We believe this uniquely positions us for significant market share gains.”




Key Business Metrics
(In Thousands, Except for Monthly Online Revenue per Average Subscriber and AOV, Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
20232022% Change20232022% Change
Subscribers (end of period)1,300 748 74 %1,300 748 74 %
Monthly Online Revenue per Average Subscriber$53 $51 4 %$55 $52 6 %
Net Orders2,109 1,385 52 %4,156 2,592 60 %
AOV$95 $78 22 %$93 $78 19 %

Revenue
(In Thousands, Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
20232022% Change20232022% Change
Online Revenue$201,178 $107,462 87 %$385,353 $201,564 91 %
Wholesale Revenue6,734 6,101 10 %13,329 13,313 — %
Total revenue$207,912 $113,563 83 %$398,682 $214,877 86 %

Second Quarter 2023 Financial Highlights
•Revenue was $207.9 million for the second quarter of 2023 compared to $113.6 million for the second quarter of 2022, an increase of 83% year-over-year.
•Gross margin was 82% for the second quarter of 2023 compared to 77% for the second quarter of 2022.
•Net loss was $(7.2) million for the second quarter of 2023 compared to $(19.7) million for the second quarter of 2022.
•Adjusted EBITDA was $10.6 million for the second quarter of 2023 compared to $(7.5) million for the second quarter of 2022.

A reconciliation of Adjusted EBITDA, a non-GAAP measure, to net loss, its most comparable financial measure under generally accepted accounting principles in the United States (“U.S. GAAP”), has been provided in this press release in the accompanying tables. Additional information about Adjusted EBITDA is also included below under the heading “Non-GAAP Financial Measures”.

Financial Outlook

Hims & Hers is providing the following guidance:

For the third quarter 2023, we expect:
•Revenue of $217 million to $222 million.
•Adjusted EBITDA of $10 million to $13 million, reflecting an Adjusted EBITDA margin of 5% to 6%.

For the full year 2023, we expect:
•Revenue of $830 million to $850 million.
•Adjusted EBITDA of $35 million to $40 million, reflecting an Adjusted EBITDA margin of 4% to 5%.



The guidance provided above constitutes forward-looking statements and actual results may differ materially. Refer to the “Cautionary Note Regarding Forward-Looking Statements” safe harbor section below for information on the factors that could cause our actual results to differ materially from these forward-looking statements.

We have not reconciled forward-looking Adjusted EBITDA to its most directly comparable U.S. GAAP measure, net loss, because we cannot predict with reasonable certainty the ultimate outcome of certain components of such reconciliations, including market-related assumptions that are not within our control, or others that may arise, without unreasonable effort. For these reasons, we are unable to assess the probable significance of the unavailable information, which could materially impact the amount of future net loss. See “Non-GAAP Financial Measures” for additional important information regarding Adjusted EBITDA.

Conference Call

Hims & Hers will host a conference call to review the second quarter 2023 results on August 7, 2023, at 5:00 p.m. ET. The conference call can be accessed by dialing +1 (888) 510-2630 for U.S. participants and +1 (646) 960-0137 for international participants, and referencing conference ID #1704296. A live audio webcast will be available online at https://investors.forhims.com/. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call at the same link.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.

We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

For more information, please visit https://investors.forhims.com/.



Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believe,” “estimate,” “anticipate,” “expect,” “assume,” “imply,” “intend,” “plan,” “may,” “will,” “potential,” “project,” “predict,” “continue,” “could,” or “should,” or, in each case, their plural, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our financial outlook and guidance, including our mission to drive top-line growth and profitability and our ability to attain our long-term financial targets; our expected future financial and business performance, including with respect to the Hims & Hers platform, our marketing campaigns, investments in innovation, and our infrastructure, and the underlying assumptions with respect to the foregoing; statements relating to events and trends relevant to us, including with respect to our financial condition, results of operations, short- and long-term business operations, objectives, and financial needs; expectations regarding our mobile applications, market acceptance, user experience, customer retention, brand development, our ability to invest and generate a return on any such investment, customer acquisition costs, operating efficiencies and leverage (including our fulfillment capabilities), the effect of any pricing decisions, changes in our product or offering mix, the timing and market acceptance of any new products or offerings, the success of our business model, our market opportunity, our ability to scale our business, the growth of certain of our categories, our ability to innovate on and expand the scope of our offerings and experiences, our ability to reinvest into the customer experience, and our ability to comply with the extensive, complex and evolving regulatory requirements applicable to our business, including without limitation state and federal healthcare, privacy and consumer protection laws and regulations. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the “Risk Factors” section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Securities and Exchange Commission (the “Commission”).

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in reports we


have filed or will file with the Commission, including our most recently filed Annual Report on Form 10-K, our most recently filed Quarterly Report on Form 10-Q, and any of our subsequent filings with the Commission. In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in such reports, those results or developments may not be indicative of results or developments in subsequent periods.

Key Business Metrics

“Online Revenue” represents the sales of products and services on our platform, net of refunds, credits, and chargebacks, and includes revenue recognition adjustments recorded pursuant to U.S. GAAP, primarily relating to deferred revenue and returns reserve. Online Revenue is generated by selling directly to consumers through our websites and mobile applications. Our Online Revenue consists of products and services purchased by customers directly through our online platform. The majority of our Online Revenue is subscription-based, where customers agree to be billed on a recurring basis to have products and services automatically delivered to them.

“Wholesale Revenue” represents non-prescription product sales to retailers through wholesale purchasing agreements. We sell only non-prescription products to wholesale partners. In addition to being revenue generative and profitable, wholesale partnerships have the added benefit of generating brand awareness with new customers in physical environments.

“Subscribers” are customers who have one or more “Subscriptions”, which are agreements pursuant to which they have agreed to be automatically billed on a recurring basis at a defined cadence. The Subscription billing cadence is typically defined as a number of months (for example, billed every month or every three months), which are excluded from our reporting when payment has not occurred at the contracted billing cadence. Subscribers can cancel Subscriptions in between billing periods to stop receiving additional products and services and can reactivate Subscriptions to continue receiving additional products and services.

“Monthly Online Revenue per Average Subscriber” is defined as Online Revenue divided by “Average Subscribers”, which amount is then further divided by the number of months in a period. “Average Subscribers” are calculated as the sum of the Subscribers at the beginning and end of a given period divided by 2.

“Net Orders” are defined as the number of online customer orders minus transactions related to refunds, credits, chargebacks, and other negative adjustments. Net Orders represent transactions made on our platform during a defined period of time and exclude revenue recognition adjustments recorded pursuant to U.S. GAAP.

Average Order Value (“AOV”) is defined as Online Revenue divided by Net Orders.


CONDENSED CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Share and Per Share Data, Unaudited)
June 30, 2023December 31, 2022
(Unaudited)
Assets
Current assets:
Cash and cash equivalents$65,417 $46,772 
Short-term investments127,725 132,853 
Inventory21,417 21,562 
Prepaid expenses and other current assets20,089 15,408 
Total current assets234,648 216,595 
Restricted cash856 856 
Goodwill110,881 110,881 
Intangibles, net19,962 21,841 
Operating lease right-of-use assets4,735 4,936 
Other long-term assets18,802 11,232 
Total assets$389,884 $366,341 
Liabilities and stockholders' equity
Current liabilities:
Accounts payable$38,267 $32,363 
Accrued liabilities19,607 12,448 
Deferred revenue2,058 1,472 
Earn-out liabilities4,776 — 
Operating lease liabilities1,839 1,658 
Total current liabilities66,547 47,941 
Operating lease liabilities3,252 3,649 
Earn-out liabilities— 2,975 
Other long-term liabilities14 35 
Total liabilities69,813 54,600 
Commitments and contingencies
Stockholders' equity:
Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 202,419,498 and 200,051,689 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of June 30, 2023 and December 31, 2022
21 21 
Additional paid-in capital682,161 656,626 
Accumulated other comprehensive loss(258)(277)
Accumulated deficit(361,853)(344,629)
Total stockholders' equity320,071 311,741 
Total liabilities and stockholders' equity$389,884 $366,341 


CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(In Thousands, Except Share and Per Share Data, Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Revenue$207,912 $113,563 $398,682 $214,877 
Cost of revenue37,754 26,387 75,099 52,945 
Gross profit170,158 87,176 323,583 161,932 
Gross margin %82 %77 %81 %75 %
Operating expenses:(1)
Marketing107,219 60,490 204,464 108,583 
Operations and support29,227 17,448 55,409 33,131 
Technology and development11,804 6,861 22,552 12,949 
General and administrative31,144 22,567 61,657 44,378 
Total operating expenses179,394 107,366 344,082 199,041 
Loss from operations(9,236)(20,190)(20,499)(37,109)
Other income:
Change in fair value of liabilities(173)121 (468)562 
Other income, net2,239 402 4,116 722 
Total other income, net2,066 523 3,648 1,284 
Loss before income taxes(7,170)(19,667)(16,851)(35,825)
Benefit (provision) for income taxes13 (12)(373)(106)
Net loss(7,157)(19,679)(17,224)(35,931)
Other comprehensive (loss) income(147)(145)19 (331)
Total comprehensive loss$(7,304)$(19,824)$(17,205)$(36,262)
Net loss per share attributable to common stockholders:
Basic and diluted$(0.03)$(0.10)$(0.08)$(0.18)
Weighted average shares outstanding:
Basic and diluted208,422,825 203,949,535 207,785,104 203,326,215 
______________ 
(1)Includes stock-based compensation expense as follows (in thousands):


Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Marketing$1,487 $1,072 $2,483 $1,895 
Operations and support1,854 667 3,008 1,153 
Technology and development2,092 1,090 3,553 1,996 
General and administrative11,412 7,803 21,968 14,444 
Total stock-based compensation expense$16,845 $10,632 $31,012 $19,488 



CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands, Unaudited)
Six Months Ended June 30,
20232022
Operating activities
Net loss$(17,224)$(35,931)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization4,494 3,562 
Stock-based compensation31,012 19,488 
Change in fair value of liabilities468 (562)
Net (accretion) amortization on securities(2,517)863 
Benefit for deferred taxes(20)(258)
Impairment of long-lived assets429 — 
Non-cash operating lease cost914 755 
Non-cash acquisition-related costs1,066 58 
Non-cash other75 — 
Changes in operating assets and liabilities:
Inventory145 (6,115)
Prepaid expenses and other current assets(4,756)(6,762)
Other long-term assets(32)(27)
Accounts payable5,438 7,453 
Accrued liabilities7,159 150 
Deferred revenue586 (851)
Operating lease liabilities(928)(772)
Earn-out payable— (6,848)
Net cash provided by (used in) operating activities26,309 (25,797)
Investing activities
Purchases of investments(65,376)(89,146)
Maturities of investments72,334 101,259 
Proceeds from sales of investments676 22,291 
Investment in website and mobile application development and internal-use software(4,062)(2,397)
Purchases of property, equipment, and intangible assets(5,312)(276)
Deferred consideration paid for acquisitions— (459)
Net cash (used in) provided by investing activities(1,740)31,272 
Financing activities
Proceeds from exercise of vested stock options560 1,470 
Payments for taxes related to net share settlement of equity awards(7,411)(1,183)
Proceeds from employee stock purchase plan898 553 
Payments for earn-out consideration for acquisitions— (23,014)
Net cash used in financing activities(5,953)(22,174)
Foreign currency effect on cash and cash equivalents29 (52)
Increase (decrease) in cash, cash equivalents, and restricted cash18,645 (16,751)
Cash, cash equivalents, and restricted cash at beginning of period47,628 72,640 
Cash, cash equivalents, and restricted cash at end of period$66,273 $55,889 
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents$65,417 $55,033 
Restricted cash856 856 
Total cash, cash equivalents, and restricted cash$66,273 $55,889 
Supplemental disclosures of cash flow information
Cash paid for taxes$626 $528 
Non-cash investing and financing activities
Purchase of property and equipment included in accounts payable$466 $— 
Right-of-use asset obtained in exchange for lease liability591 — 
Vesting of early exercised stock options— 76 


Non-GAAP Financial Measures
In addition to our financial results determined in accordance with U.S. GAAP, we present Adjusted EBITDA (which is a non-GAAP financial measure), and Adjusted EBITDA margin (which is a non-GAAP ratio), each as defined below. We use Adjusted EBITDA and Adjusted EBITDA margin to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that Adjusted EBITDA and Adjusted EBITDA margin, when taken together with the corresponding U.S. GAAP financial measures, provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations, or outlook. We consider Adjusted EBITDA and Adjusted EBITDA margin to be important measures because they help illustrate underlying trends in our business and our historical operating performance on a more consistent basis. We believe that the use of Adjusted EBITDA and Adjusted EBITDA margin is helpful to our investors as they are used by management in assessing the health of our business and our operating performance.

However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with U.S. GAAP. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP financial measures or ratios differently or may use other financial measures or ratios to evaluate their performance, all of which could reduce the usefulness of Adjusted EBITDA or Adjusted EBITDA margin as tools for comparison. Reconciliations are provided below to the most directly comparable financial measures stated in accordance with U.S. GAAP. Investors are encouraged to review our U.S. GAAP financial measures and not to rely on any single financial measure to evaluate our business.

Adjusted EBITDA is a key performance measure that our management uses to assess our operating performance. Because Adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes. “Adjusted EBITDA” is defined as net loss before stock-based compensation, depreciation and amortization, acquisition-related costs (which includes consideration paid for employee compensation with vesting requirements incurred directly as a result of acquisitions, inclusive of revaluation of earn-out consideration recorded in general and administrative expenses), change in fair value of liabilities, impairment of long-lived assets, income taxes, and interest income. “Adjusted EBITDA margin” is defined as Adjusted EBITDA divided by revenue.

Some of the limitations of Adjusted EBITDA include (i) Adjusted EBITDA does not properly reflect capital commitments to be paid in the future, and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. We compensate for these limitations by providing specific information regarding the U.S. GAAP items excluded from Adjusted EBITDA. When evaluating our performance, you should consider Adjusted EBITDA in addition to, and not as a substitute for, other financial performance measures, including our net loss and other U.S. GAAP results.



Net Loss to Adjusted EBITDA Reconciliation
(In Thousands, Unaudited)
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Revenue$207,912 $113,563 $398,682 $214,877 
Net loss(7,157)(19,679)(17,224)(35,931)
Stock-based compensation16,845 10,632 31,012 19,488 
Depreciation and amortization2,377 1,821 4,494 3,562 
Acquisition-related costs583 150 1,229 266 
Change in fair value of liabilities173 (121)468 (562)
Impairment of long-lived assets— — 429 — 
(Benefit) provision for income taxes(13)12 373 106 
Interest income (2,173)(356)(4,086)(531)
Adjusted EBITDA$10,635 $(7,541)$16,695 $(13,602)
Net loss as a % of revenue(3)%(17)%(4)%(17)%
Adjusted EBITDA margin5 %(7)%4 %(6)%


Contacts:
Investor Relations
Alice Lopatto
Investors@forhims.com

Media Relations
Press@forhims.com